From: Abbott Biologicals B.V. To: Mymetics Corporation Date: May 23, 2011 Subject: Termination License and Cooperation Agreements for Intranasal Delivery ofAPRECS based Vaccines and Virosome based Vaccines; your email dated May 10, 2011.Mymetics Corp • November 14th, 2011 • Biological products, (no disgnostic substances)
In response to your email dated May 10, 2011, Abbott is still willing to assist Mymetics by lowering the royalty percentage as mentioned in article 13.8 of both above mentioned agreements from 25% to 10% and leaving the other conditions in our letter of April 28, 2011, unchanged.
